Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system

S. Li, Subbiah Sivam, J. S. Hong

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The purpose of this study was to explore the dopaminergic control of the striatonigral dynorphin system by measuring the levels of dynorphin A1-8-like immunoreactivity (DN-LI) after repeated injections of a dopaminergic receptor agonist or antagonist. Seven daily injections of different doses of apomorphine (0.5, 1.0, 2.5 and 5.0 mg/kg, s.c.) caused a significant dose-related increase of DN-LI in the striatum (26, 34, 63, 85% over control at each corresponding dose). Similar increases were observed in the substantia nigra (22, 52, 50 and 62% over control). In another experiment, rats received 5 mg/kg of apomorphine for 1, 3, and 7 days. There was a significant time-related increase in DN-LI both in the striatum (37, 50 and 85% over control at each corresponding period) and in the substantia nigra (32, 78 and 62%). Repeated administration of haloperidol (1 mg/kg, i.p.) failed to change the striatal level of DN-LI, but, when given at the same time as apomorphine, significantly attenuated the effect of apomorphine. These results suggest that dopamine exerts a modulatory influence on the metabolism of dynorphin in the striatonigral pathway.

Original languageEnglish (US)
Pages (from-to)390-392
Number of pages3
JournalBrain Research
Volume398
Issue number2
DOIs
StatePublished - Nov 29 1986
Externally publishedYes

Fingerprint

Dynorphins
Apomorphine
Substantia Nigra
Corpus Striatum
Injections
Dopamine Antagonists
Dopamine Agonists
Haloperidol
Dopamine

Keywords

  • Dopamine
  • Dynorphin
  • Striatonigral pathway

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system. / Li, S.; Sivam, Subbiah; Hong, J. S.

In: Brain Research, Vol. 398, No. 2, 29.11.1986, p. 390-392.

Research output: Contribution to journalArticle

@article{cc2153bb7b254922843ff06aaeaa8fff,
title = "Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system",
abstract = "The purpose of this study was to explore the dopaminergic control of the striatonigral dynorphin system by measuring the levels of dynorphin A1-8-like immunoreactivity (DN-LI) after repeated injections of a dopaminergic receptor agonist or antagonist. Seven daily injections of different doses of apomorphine (0.5, 1.0, 2.5 and 5.0 mg/kg, s.c.) caused a significant dose-related increase of DN-LI in the striatum (26, 34, 63, 85{\%} over control at each corresponding dose). Similar increases were observed in the substantia nigra (22, 52, 50 and 62{\%} over control). In another experiment, rats received 5 mg/kg of apomorphine for 1, 3, and 7 days. There was a significant time-related increase in DN-LI both in the striatum (37, 50 and 85{\%} over control at each corresponding period) and in the substantia nigra (32, 78 and 62{\%}). Repeated administration of haloperidol (1 mg/kg, i.p.) failed to change the striatal level of DN-LI, but, when given at the same time as apomorphine, significantly attenuated the effect of apomorphine. These results suggest that dopamine exerts a modulatory influence on the metabolism of dynorphin in the striatonigral pathway.",
keywords = "Dopamine, Dynorphin, Striatonigral pathway",
author = "S. Li and Subbiah Sivam and Hong, {J. S.}",
year = "1986",
month = "11",
day = "29",
doi = "10.1016/0006-8993(86)91502-7",
language = "English (US)",
volume = "398",
pages = "390--392",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system

AU - Li, S.

AU - Sivam, Subbiah

AU - Hong, J. S.

PY - 1986/11/29

Y1 - 1986/11/29

N2 - The purpose of this study was to explore the dopaminergic control of the striatonigral dynorphin system by measuring the levels of dynorphin A1-8-like immunoreactivity (DN-LI) after repeated injections of a dopaminergic receptor agonist or antagonist. Seven daily injections of different doses of apomorphine (0.5, 1.0, 2.5 and 5.0 mg/kg, s.c.) caused a significant dose-related increase of DN-LI in the striatum (26, 34, 63, 85% over control at each corresponding dose). Similar increases were observed in the substantia nigra (22, 52, 50 and 62% over control). In another experiment, rats received 5 mg/kg of apomorphine for 1, 3, and 7 days. There was a significant time-related increase in DN-LI both in the striatum (37, 50 and 85% over control at each corresponding period) and in the substantia nigra (32, 78 and 62%). Repeated administration of haloperidol (1 mg/kg, i.p.) failed to change the striatal level of DN-LI, but, when given at the same time as apomorphine, significantly attenuated the effect of apomorphine. These results suggest that dopamine exerts a modulatory influence on the metabolism of dynorphin in the striatonigral pathway.

AB - The purpose of this study was to explore the dopaminergic control of the striatonigral dynorphin system by measuring the levels of dynorphin A1-8-like immunoreactivity (DN-LI) after repeated injections of a dopaminergic receptor agonist or antagonist. Seven daily injections of different doses of apomorphine (0.5, 1.0, 2.5 and 5.0 mg/kg, s.c.) caused a significant dose-related increase of DN-LI in the striatum (26, 34, 63, 85% over control at each corresponding dose). Similar increases were observed in the substantia nigra (22, 52, 50 and 62% over control). In another experiment, rats received 5 mg/kg of apomorphine for 1, 3, and 7 days. There was a significant time-related increase in DN-LI both in the striatum (37, 50 and 85% over control at each corresponding period) and in the substantia nigra (32, 78 and 62%). Repeated administration of haloperidol (1 mg/kg, i.p.) failed to change the striatal level of DN-LI, but, when given at the same time as apomorphine, significantly attenuated the effect of apomorphine. These results suggest that dopamine exerts a modulatory influence on the metabolism of dynorphin in the striatonigral pathway.

KW - Dopamine

KW - Dynorphin

KW - Striatonigral pathway

UR - http://www.scopus.com/inward/record.url?scp=0023005590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023005590&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(86)91502-7

DO - 10.1016/0006-8993(86)91502-7

M3 - Article

C2 - 2879611

AN - SCOPUS:0023005590

VL - 398

SP - 390

EP - 392

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -